rosiglitazone
Showing 1 - 25 of 121
Polycystic Ovary Syndrome Trial in Sherbrooke (Rosiglitazone, Acarbose)
Completed
- Polycystic Ovary Syndrome
- Rosiglitazone
- Acarbose
-
Sherbrooke, Quebec, CanadaUniversité de Sherbrooke
Jan 4, 2022
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Malaria Trial in Manhiça (Rosiglitazone, Placebo)
Unknown status
- Malaria
- Rosiglitazone
- Placebo
-
Manhiça, Maputo, MozambiqueCentro de Investigação em Saude da Manhiça
Jan 26, 2021
Alzheimer's Disease Trial in Canada, United Kingdom, United States (Rosiglitazone, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone
- Placebo
-
Litchfield Park, Arizona
- +14 more
Oct 27, 2020
Diabetes, Type II Trial in United States (Metformin, Rosiglitazone, Lifestyle Program)
Completed
- Diabetes Mellitus, Type II
- Metformin
- +2 more
-
Los Angeles, California
- +15 more
Jul 28, 2021
Healthy Trial in Montpellier (rosiglitazone)
Completed
- Healthy
- rosiglitazone
-
Montpellier, FranceCentre d'Investigation Clinique
Jun 7, 2019
Tumors Trial in Canada (Regorafenib (Stivarga, BAY73-4506), Warfarin, Omeprazole)
Completed
- Neoplasms
- Regorafenib (Stivarga, BAY73-4506)
- +4 more
-
Edmonton, Alberta, Canada
- +3 more
Jul 8, 2019
Diabetic Patients - Pilot Study
Withdrawn
- Diabetes Mellitus, Type 2
- Rosiglitazone
-
Cambridge, United Kingdom
- +3 more
Jul 8, 2019
Diabetes, Type 2 Trial in Japan (Rosiglitazone)
Completed
- Diabetes Mellitus, Type 2
- Rosiglitazone
-
Hokkaido, Japan
- +5 more
Aug 30, 2018
Diabetes, Type II Trial in Saint Louis (Metformin, Rosiglitazone, Lovaza)
Completed
- Diabetes Mellitus, Type II
- Metformin
- +2 more
-
Saint Louis, MissouriWashington University in St. Louis
Aug 24, 2018
Type 2 Diabetes Trial in Seattle (rosiglitazone, glyburide)
Completed
- Type 2 Diabetes Mellitus
- rosiglitazone
- glyburide
-
Seattle, WashingtonDVA Puget Sound Health Care System
Mar 27, 2018
Metabolic Syndrome, Impaired Glucose Tolerance Trial in Berlin (rosiglitazone)
Completed
- Metabolic Syndrome
- Impaired Glucose Tolerance
- rosiglitazone
-
Berlin, GermanyCharite, Campus Benjamin Franklin
Jan 11, 2018
Ulcerative Colitis, Inflammatory Bowel Disease Trial in United States (Rosiglitazone, Placebo)
Completed
- Ulcerative Colitis
- Inflammatory Bowel Disease
- Rosiglitazone
- Placebo
-
Atlanta, Georgia
- +12 more
Dec 14, 2017
Pituitary Tumor Trial in Shanghai (Rosiglitazone)
Unknown status
- Pituitary Tumor
- Rosiglitazone
-
Shanghai, Shanghai, ChinaHuashan Hospital
Oct 9, 2017
Diabetes, Type 2 Trial (rosiglitazone)
Completed
- Diabetes Mellitus, Type 2
- rosiglitazone
- (no location specified)
Oct 5, 2017
Polycystic Ovary Syndrome Trial in Pittsburgh (rosiglitazone, drospirenone/ethinyl estradiol)
Completed
- Polycystic Ovary Syndrome
- rosiglitazone
- drospirenone/ethinyl estradiol
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh
Oct 16, 2017
Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +3 more
-
Hueytown, Alabama
- +102 more
Sep 3, 2018
Nausea and Vomiting, Chemo-Induced Trial in Evansville (casopitant, dolasetron, granisetron)
Completed
- Nausea and Vomiting, Chemotherapy-Induced
- casopitant
- +3 more
-
Evansville, IndianaGSK Investigational Site
Aug 2, 2017
Diabetes, Type 2 Trial (Rosiglitazone)
Completed
- Diabetes Mellitus, Type 2
- Rosiglitazone
- (no location specified)
Oct 5, 2017
Diabetes, Type 2 Trial (Rosiglitazone)
Completed
- Diabetes Mellitus, Type 2
- Rosiglitazone
- (no location specified)
Oct 5, 2017
Asthma Trial in Wellington (Rosiglitazone, Placebo)
Completed
- Asthma
- Rosiglitazone
- Placebo
-
Wellington, New ZealandGSK Investigational Site
Sep 21, 2017
Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Metformin)
Alzheimer's Disease Trial in Canada, United States (rosiglitazone)
Completed
- Alzheimer's Disease
- rosiglitazone
-
Litchfield Park, Arizona
- +6 more
Apr 18, 2017
Diabetes, Type 2 Trial in Buffalo (GSK376501, Midazolam, Rosiglitazone)
Completed
- Diabetes Mellitus, Type 2
- GSK376501
- +3 more
-
Buffalo, New YorkGSK Investigational Site
Sep 8, 2017